This article is more than 5 years old. Information may no longer be current.

Eyenuk launches AI diabetic retinopathy screening service

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Eyenuk has launched its EyeScreen Human + AI Diagnostic Service for diabetic retinopathy, according to a press release.

The artificial intelligence technology connects primary care and diabetes care clinics with eye care specialists to increase access to DR screening, reduce wait times and improve patient compliance in receiving screenings, the release said.

It provides for screenings in a clinic setting, allowing any physician the ability to identify DR sooner and begin treatment faster.

“The EyeScreen Service is our unique take on combining expert human grading with a validated autonomous AI system, allowing users to benefit from the best of both worlds,” Eyenuk CEO Kaushal Solanki said in the release. “We are thrilled to empower physicians with the ability to screen patients in clinic without requiring dilation, for the best chance of early DR detection.”